第一单位：
Hereditary Cancer Program, Catalan Institute of Oncology (ICO - IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
作者：
Mireia,Gausachs [1]
;
Ester,Borras [2]
;
Kyle,Chang [3]
;
Sara,Gonzalez [4]
;
Daniel,Azuara [4]
;
Axel,Delgado Amador [2]
;
Adriana,Lopez-Doriga [5]
;
F Anthony,San Lucas [6]
;
Xavier,Sanjuan [7]
;
Maria J,Paules [7]
;
Melissa W,Taggart [8]
;
Gareth E,Davies [9]
;
Erik A,Ehli [9]
;
Jerry,Fowler [6]
;
Victor,Moreno [10]
;
Marta,Pineda [4]
;
Y Nancy,You [11]
;
Patrick M,Lynch [12]
;
Conxi,Lazaro [4]
;
Nicholas E,Navin [13]
;
Paul A,Scheet [14]
;
Ernest T,Hawk [2]
;
Gabriel,Capella [15]
;
Eduardo,Vilar [16]
作者单位：
Hereditary Cancer Program, Catalan Institute of Oncology (ICO - IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
[1]
Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas.
[2]
Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas.;Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas.
[3]
Hereditary Cancer Program, Catalan Institute of Oncology (ICO - IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.;CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.
[4]
Cancer Prevention and Control Program, Catalan Institute of Oncology (ICO-IDIBELL) and CIBERESP, L'Hospitalet de Llobregat, Barcelona, Spain.
[5]
Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
[6]
Department of Pathology, University Hospital Bellvitge (HUB - IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
[7]
Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
[8]
Avera Institute for Human Genetics, Sioux Falls, South Dakota.
[9]
Cancer Prevention and Control Program, Catalan Institute of Oncology (ICO-IDIBELL) and CIBERESP, L'Hospitalet de Llobregat, Barcelona, Spain.;Department of Clinical Sciences, Medical School, University of Barcelona, Barcelona, Spain.
[10]
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.;Clinical Cancer Genetics Program, The University of Texas MD Anderson Cancer Center, Houston, Texas.
[11]
Clinical Cancer Genetics Program, The University of Texas MD Anderson Cancer Center, Houston, Texas.;Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas.
[12]
Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas.;Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
[13]
Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas.;Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
[14]
Hereditary Cancer Program, Catalan Institute of Oncology (ICO - IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain. EVilar@mdanderson.org gcapella@iconcologia.net.;CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.
[15]
Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas. EVilar@mdanderson.org gcapella@iconcologia.net.;Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas.;Clinical Cancer Genetics Program, The University of Texas MD Anderson Cancer Center, Houston, Texas.;Department of GI Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
[16]
DOI
10.1158/1078-0432.CCR-17-0821
PMID
28645942
发布时间
2018-11-13
换一批
